Literature DB >> 7656133

The current status of the Papanicolaou smear.

H M Shingleton1, R L Patrick, W W Johnston, R A Smith.   

Abstract

Since its introduction as a screen for cervical cancer in the late 1940s, the Pap smear has become one of the most widely accepted screening procedures for cancer. Numerous scientific studies have now attested to its effectiveness. However, important issues related to the Pap smear, including cytologic nomenclature, accuracy, regulatory procedures, and screening guidelines, are still being evaluated and debated. This article provides an overview of important issues related to the Pap smear.

Entities:  

Mesh：

Year:  1995        PMID： 7656133     DOI： 10.3322/canjclin.45.5.305

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN： 0007-9235            Impact factor:   508.702


  8 in total

Review 1.  How can we develop a cost-effective quality cervical screening programme?

Authors:  Sue Wilson; Helen Lester
Journal:  Br J Gen Pract       Date:  2002-06       Impact factor: 5.386

2.  Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancer.

Authors:  Kerstin Heselmeyer-Haddad; Kathrin Sommerfeld; Nicole M White; Nadia Chaudhri; Larry E Morrison; Nallasivam Palanisamy; Zhen Yuan Wang; Gert Auer; Winfried Steinberg; Thomas Ried
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

3.  Low false-negative rate of PCR analysis for detecting human papillomavirus-related cervical lesions.

Authors:  P Zazove; B D Reed; L Gregoire; A Ferenczy; D W Gorenflo; W D Lancaster
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

4.  Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia.

Authors:  Kerstin Heselmeyer-Haddad; Viktor Janz; Philip E Castle; Nadia Chaudhri; Nicole White; Kim Wilber; Larry E Morrison; Gert Auer; Frances H Burroughs; Mark E Sherman; Thomas Ried
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

Review 5.  A systematic scoping review on utility of cytomorphometry in the detection of dysplasia in oral potentially malignant disorders.

Authors:  Monal Yuwanati; Amol Gadbail; Shailesh Gondivkar; Sachin C Sarode; Ravi Dande; Shubhangi Mhaske; Satayjit Tekade; Sandeep Kumar Pathak
Journal:  J Oral Biol Craniofac Res       Date:  2020-07-03

6.  Proteomics and mass spectrometry for cancer biomarker discovery.

Authors:  Ming Lu; Kym F Faull; Julian P Whitelegge; Jianbo He; Dejun Shen; Romaine E Saxton; Helena R Chang
Journal:  Biomark Insights       Date:  2007-10-03

7.  Evaluation of a real-time optoelectronic method in the diagnostics of CIN over four years of observations.

Authors:  Barbara Suchońska; Wanda Gajzlerska-Majewska; Mirosław Wielgoś
Journal:  PLoS One       Date:  2021-02-26       Impact factor: 3.240

8.  Anal human papillomavirus infection and its relationship with abnormal anal cytology among MSM with or without HIV infection in Japan.

Authors:  Daisuke Shiojiri; Daisuke Mizushima; Misao Takano; Koji Watanabe; Naokatsu Ando; Haruka Uemura; Yasuaki Yanagawa; Takahiro Aoki; Junko Tanuma; Kunihisa Tsukada; Katsuji Teruya; Yoshimi Kikuchi; Hiroyuki Gatanaga; Shinichi Oka
Journal:  Sci Rep       Date:  2021-09-28       Impact factor: 4.379
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.